Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Young academic receives BRICS research funding
2017-04-13

Description: Dr Thulisile Mphambukeli  Tags: Dr Thulisile Mphambukeli

Dr Thulisile Mphambukeli and Dr Victor Okorie
from the Department of Urban and Regional Planning
at the University of the Free State.
Photo: Rulanzen Martin

“It means a lot to me, as I am a young academic embarking on my postdoctoral research project. To be able to lead a team of researchers from various research institutions in South Africa is humbling.” This is what Dr Thulisile Mphambukeli had to say on being awarded a research grant by the South African BRICS Think Tank.

The think tank, in collaboration with the National Institute for the Humanities and Social Sciences (NIHSS), awarded the lecturer in Urban and Regional Planning at the University of the Free State (UFS) R150 000. She will spearhead a research project between BRICS (Brazil, Russia, India, China, and South Africa) universities. “They have awarded me a three-month grant to facilitate a process of combining various research projects under the BRICS Academic Cluster,” Dr Mphambukeli said.

Platform provides collaboration

“The academic cluster provides a platform for researchers and academics to engage in ongoing collaboration,” she said. The grant will enable her and her research partner, Dr Victor Okorie, postdoctoral fellow in the Department of Urban and Regional Planning at the UFS, to put together a research proposal to be submitted at the end of May 2017. If successful, her team will conduct a research study across BRICS countries over a period of three years. It will be done in collaboration with various South African universities, who will form a team to collaborate with researchers from BRICS universities.

Great accomplishment for UFS
“The funds we have received are quite a great accomplishment for the UFS and our department,” Dr Okorie said. The UFS has become a force to be reckoned with when it comes to emerging issues in BRICS politics and policies. “Our project looks at the provision of ecosystems, agriculture, and security and the UFS was chosen as the host institution.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept